» Articles » PMID: 24731292

Epimorphin(-/-) Mice Are Protected, in Part, from Acute Colitis Via Decreased Interleukin 6 Signaling

Overview
Journal Transl Res
Publisher Elsevier
Specialty Pathology
Date 2014 Apr 16
PMID 24731292
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Epimorphin (Epim), a member of the syntaxin family of membrane-bound, intracellular vesicle-docking proteins, is expressed in intestinal myofibroblasts and macrophages. We demonstrated previously that Epimorphin(-/-)(Epim(-/-)) mice are protected, in part, from dextran sodium sulfate (DSS)-induced colitis. Although interleukin (IL)-6/p-Stat3 signaling has been implicated in the pathogenesis of colitis, the myofibroblast contribution to IL-6 signaling in colitis remains unexplored. Our aim was to investigate the IL-6 pathway in Epim(-/-) mice in the DSS colitis model. Whole colonic tissue, epithelium, and stroma of WT and congenic Epim(-/-) mice treated with 5% DSS for 7 days were analyzed for IL-6 and a downstream effector, p-Stat3, by immunostaining and immunoblot. Colonic myofibroblast and peritoneal macrophage IL-6 secretion were evaluated by enzyme-linked immunosorbent assay. IL-6 and p-Stat3 expression were decreased in Epim(-/-) vs WT colon. A relative increase in stromal vs epithelial p-Stat3 expression was observed in WT mice but not in Epim(-/-) mice. Epim deletion abrogates IL-6 secretion from colonic myofibroblasts treated with IL-1β and decreases IL-6 secretion from peritoneal macrophages in a subset of DSS-treated mice. Epim deletion inhibits IL-6 secretion most profoundly from colonic myofibroblasts. Distribution of Stat3 activation is altered in DSS-treated Epim(-/-) mice. Our findings support the notion that myofibroblasts modulate IL-6/p-Stat3 signaling in DSS-treated Epim(-/-) mice.

Citing Articles

Interleukin 6 inhibition by triptolide prevents inflammation in a mouse model of ulcerative colitis.

Zhang H, Chen W Exp Ther Med. 2017; 14(3):2271-2276.

PMID: 28962154 PMC: 5609133. DOI: 10.3892/etm.2017.4778.


Graded effects of unregulated smooth muscle myosin on intestinal architecture, intestinal motility and vascular function in zebrafish.

Abrams J, Einhorn Z, Seiler C, Zong A, Sweeney H, Pack M Dis Model Mech. 2016; 9(5):529-40.

PMID: 26893369 PMC: 4892660. DOI: 10.1242/dmm.023309.


IKKβ in intestinal mesenchymal cells promotes initiation of colitis-associated cancer.

Koliaraki V, Pasparakis M, Kollias G J Exp Med. 2015; 212(13):2235-51.

PMID: 26621453 PMC: 4683996. DOI: 10.1084/jem.20150542.


Human esophageal myofibroblasts secrete proinflammatory cytokines in response to acid and Toll-like receptor 4 ligands.

Gargus M, Niu C, Vallone J, Binkley J, Rubin D, Shaker A Am J Physiol Gastrointest Liver Physiol. 2015; 308(11):G904-23.

PMID: 25882613 PMC: 4451324. DOI: 10.1152/ajpgi.00333.2014.

References
1.
Mudter J, Neurath M . Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm Bowel Dis. 2007; 13(8):1016-23. DOI: 10.1002/ibd.20148. View

2.
Brittan M, Chance V, Elia G, Poulsom R, Alison M, Macdonald T . A regenerative role for bone marrow following experimental colitis: contribution to neovasculogenesis and myofibroblasts. Gastroenterology. 2005; 128(7):1984-95. DOI: 10.1053/j.gastro.2005.03.028. View

3.
Pinchuk I, Beswick E, Saada J, Boya G, Schmitt D, Raju G . Human colonic myofibroblasts promote expansion of CD4+ CD25high Foxp3+ regulatory T cells. Gastroenterology. 2011; 140(7):2019-30. PMC: 3109194. DOI: 10.1053/j.gastro.2011.02.059. View

4.
Li Y, Yu C, Zhu W, Xie Y, Qi X, Li N . Triptolide ameliorates IL-10-deficient mice colitis by mechanisms involving suppression of IL-6/STAT3 signaling pathway and down-regulation of IL-17. Mol Immunol. 2010; 47(15):2467-74. DOI: 10.1016/j.molimm.2010.06.007. View

5.
Bouguen G, Chevaux J, Peyrin-Biroulet L . Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases. World J Gastroenterol. 2011; 17(5):547-56. PMC: 3040326. DOI: 10.3748/wjg.v17.i5.547. View